# MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction

Study · id `cardio:ct-nct03234348` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03234348](<https://clinicaltrials.gov/study/NCT03234348>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03234348

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

## Technical summary

Registry record NCT03234348. Randomized; double masking; primary purpose treatment. Start 2017-07-01 (actual); primary completion 2019-06-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 151 participants (enrolled count; ClinicalTrials.gov record NCT03234348, source copy `cardio:ctgov-nct03234348-2020-04-17`, retrieved 2026-10-26)
- Started: 2017-07-01 (actual) (ClinicalTrials.gov record NCT03234348, source copy `cardio:ctgov-nct03234348-2020-04-17`, retrieved 2026-10-26)
- Primary completion: 2019-06-30 (actual) (ClinicalTrials.gov record NCT03234348, source copy `cardio:ctgov-nct03234348-2020-04-17`, retrieved 2026-10-26)
- Completion: 2019-10-31 (actual) (ClinicalTrials.gov record NCT03234348, source copy `cardio:ctgov-nct03234348-2020-04-17`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT03234348, source copy `cardio:ctgov-nct03234348-2020-04-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03234348-2020-04-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction
- Acronym: MAGSTEMI
- Condition: Acute Coronary Syndrome
- Condition: ST Segment Elevation Myocardial Infarction
- Condition: Stent
- Intervention (Device): Percutaneous coronary intervention
- Lead sponsor: Hospital Clinic of Barcelona
- Lead sponsor class: OTHER
- Collaborator: Spanish Society of Cardiology
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Hospital Clinic of Barcelona (`cardio:org-hospital-clinic-of-barcelona`)
- Registry lists this organization as a collaborator: Spanish Society of Cardiology (`cardio:org-spanish-society-of-cardiology`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial (`cardio:pubmed-31553204`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial (`cardio:pubmed-32310130`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0a415512bbad9ed191c1a2e717cc19359d05578fa6940f817a56ad4ae653cbe4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
